Clinical Cancer Research Journal Issues Research Articles in April 1, 2022 Edition
April 01, 2022
April 01, 2022
PHILADELPHIA, Pennsylvania, April 1 -- Clinical Cancer Research, a journal from the American Association for Cancer Research that presents clinical and translational cancer research studies that bridge the laboratory and the clinic, published research articles, including the following topics, in its April 1, 2022 edition:
Clinical Trials: Targeted Therapy:
* The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified . . .
Clinical Trials: Targeted Therapy:
* The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified . . .